Symbion bidders move to reassure pharmacy chain owner Terry White
Wednesday, May 7, 2008/
Potential bidders for Symbion’s assets have phoned Terry White chemist founder Terry White to ease pharmacists’ fears about their fate under new ownership.
The Terry White pharmacy chain contributes revenue of $350 million to $400 million a year to parent company Symbion.
White last week told The Australian Financial Review that some potential bidders had not contacted him and were “ignorant and arrogant if they believe they can move into the health-care sector without negotiating with people who are running the pharmacies”.
White today told the AFR that all bidders had since contacted him and were keen to discuss their proposals with pharmacists once they had proceeded to due diligence and were free of confidentiality agreements currently in place.
Potential bidders include Ironbride and Archer Capital (jointly), Metcash and Sigma (jointly) and Australian Pharmaceutical Industries.
Be honest about your situation: How vulnerability helps businesses thrive Sue Parker DARE Group founder
Own it: The 10 things you need to do to manage your personal brand Lisa Stephenson Who Am I Projects founder
Six invaluable lessons: What 20 years in aged care taught me about being an entrepreneur Natasha Chadwick NewDirection Care founder
An entrepreneurial superpower: Eight tips to help develop resilience Adala Bolto ZADI Training co-founder
Going through a lull? Five areas you should invest in when sales drop Tamara Alaveras and Sonia Majkic 3 Phase Marketing co-founders
Stop telling us how busy you are, it's boring and charmless Ian Whitworth Scene Change co-founder
Blandification™ and the state of modern branding Jeffrey Oley The Offices co-founder
Why you should find the right role for the right person — not the other way around Bruce Stronge Outfit founder